Clinical trial
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
NCT01741142
Study timeline
Study start (unknown)2012-01-01Date precision: month
Registry last updated2013-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
Sponsors & collaborators
AbbVie (prior sponsor, Abbott)lead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1SeattleWashington, United States1PortlandOregon, United States1AustinTexas, United States1Salt Lake CityUtah, United States1Little RockArkansas, United States1DaytonOhio, United States1BrooklynNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01741142 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.